Clinical trials

  • ELRANATAMAB for Multiple myeloma|Newly diagnosed multiple myeloma
  • ALLOGENEIC ADIPOSE-DERIVED MESENCHYMAL STROMAL CELLS, EX-VIVO EXPANDED for Stevens-Johnson syndrome / Toxic epidermal necrolysis (SJS-TEN) | Lyell syndrome
  • FERUMOXYTOL for Iron deficiency anemia | Chronic kidney disease
  • SODIUM ASCORBATE for Sepsis|Acute respiratory distress syndrome
  • Dexamethasone sodium phosphate for Multiple myeloma|Relapsed multiple myeloma (first relapse)
  • acetylsalicylic acid for Atrial fibrillation
  • TRASTUZUMAB CONJUGATED TO N-SUCCINYLDESFERRIOXAMINE B-TETRAFLUORPHENOL AND RADIOLABELED WITH ZIRCONIUM (89ZR) for Advanced HER2-positive breast cancer|Metastatic breast cancer
  • O3R-5671-PRO for Inflammatory bowel disease|Psoriasis
  • AZATHIOPRINE for Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
  • PEMBROLIZUMAB for Metastatic colorectal cancer|Locally advanced or metastatic prostate cancer
  • meropenem, vaborbactam for Complicated urinary tract infection | Acute pyelonephritis
  • naronapride for Idiopathic gastroparesis | Diabetic gastroparesis